Albertsons Companies Inc <ACI.N>: UBS cuts to Neutral from Buy; cuts target price to $12 from $20
ACI•Related News
US FDA staff cast doubt on Replimune cancer drug's benefit; shares slide
REPL•
Crinetics Pharmaceuticals Inc <CRNX.O>: UBS cuts to neutral from buy; cuts target price to $85 from $55
CRNX•
U.S. Research Roundup- BioLife Solutions, Gossamer Bio, Intuit
INTU•
Nasdaq Trade Halt <LGHL.O> Volatility Trading Pause at 10:57 AM
LGHL•
Edible Garden effects 1-for-45 reverse stock split
EDBL•